The analysis of GBM database (GBM Bio-DP) revealed that low mRNA levels of all four genes (NG2, PDGFRA, PDGFRB, and ITGB1) in MES, PN, and NE subtypes are associated with an increased patient survival. This evidence concerns the gene CSPG4 and glioblastoma.